ARA-290 (Cibinetide): Advanced Peptide for Neuroprotection, Wound Repair, and Pain Relief in Research
Discover the tissue-protective and pain-relieving potential of ARA-290, a novel peptide for advanced research applications.
Get a Quote & SampleProduct Core Value
ARA-290 Peptide
ARA-290, also known as Cibinetide, is a synthetic 11-amino acid peptide with significant tissue-protective and neuroprotective properties. Derived from Erythropoietin (EPO), it offers therapeutic benefits without stimulating red blood cell production. Its unique mechanism targets pain relief and promotes cell survival, making it a promising compound for various research applications.
- Leverage the potential of ARA-290 peptide neuroprotective effects in your research studies.
- Explore Cibinetide for wound repair applications and its role in tissue regeneration.
- Investigate the ARA-290 pain relief mechanism and its impact on neuropathic conditions.
- Understand the advantages of using this EPO derivative peptide in cutting-edge research.
Key Product Advantages
Targeted Neuroprotection
ARA-290 provides significant neuroprotective effects, crucial for understanding and treating neurological disorders. Its ability to promote cell survival is a key aspect for research in this field.
Enhanced Wound Healing
The potential of Cibinetide for wound repair, particularly in conditions like chronic diabetes, is a major area of research. This peptide stimulates natural wound repair processes.
Pain Management Potential
Delve into the ARA-290 pain relief mechanism. The peptide has shown promise in alleviating neuropathic pain by targeting specific channels, offering new avenues for pain management research.
Key Applications
Neurodegenerative Disease Research
Utilize ARA-290's neuroprotective capabilities to study and potentially treat conditions affecting nerve cells, contributing to advancements in neuroscience.
Diabetic Wound Care Studies
The potential of Cibinetide for wound repair in diabetic patients is a significant research focus, aiming to improve healing outcomes for chronic wounds.
Neuropathic Pain Studies
Investigate how ARA-290 can be used to alleviate neuropathic pain, offering insights into novel pain management strategies.
Autoimmune Disease Research
Explore the role of ARA-290 in managing conditions like systemic lupus erythematosus, contributing to a deeper understanding of autoimmune responses.